Correspondence 0001193125-25-223620 from REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC.
Date: Sept. 29, 2025 · CIK: 0001810560 · Accession: 0001193125-25-223620
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-29039
Letter
Re: Revelation Biosciences, Inc.
Revelation Biosciences, Inc. 4660 La Jolla Village Drive, Suite 100 San Diego, California 92122
September 30, 2025
Via EDGAR Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, DC 20549
Attention: Jimmy McNamara
Alan Campbell
Registration Statement on Form S-3
Commission File No. 333-29039
Messrs. McNamara and Campbell: On behalf of Revelation Biosciences, Inc. (the “Company”), I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on September 30, 2025, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Revelation Biosciences, Inc. 4660 La Jolla Village Drive, Suite 100 San Diego, California 92122 September 30, 2025 Via EDGAR Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Jimmy McNamara Alan Campbell Re: Revelation Biosciences, Inc. Registration Statement on Form S-3 Commission File No. 333-29039 Messrs. McNamara and Campbell: On behalf of Revelation Biosciences, Inc. (the “Company”), I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on September 30, 2025, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments. Very truly yours, Revelation Biosciences, Inc. /s/ Chester S. Zygmont, III Chief Financial Officer